MedDataX Logo

Psychoeducation for Adults With Autism and Their Significant Others/Family Members

NCT04460976 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 718

Last updated 2020-12-14

No results posted yet for this study

Summary

Prisma is a four-session psychoeducational intervention administered in groups for individuals with ASD together with their family members and significant others. The aspiration is to make Prisma into an affordable, accessible and available intervention. This includes taking into account a great age spectrum, differences in comorbidity as well as other varied qualities that characterize this group. Acknowledging this diversity and helping to create opportunity for these individuals is of great importance in order to follow national as well as international legislations of the patient's rights.

The aim of the proposed studies is to evaluate the feasibility and effect of Prisma in adults (18 or over) with ASD and their family members/significant others in an outpatient clinical habilitation context.

Conditions

  • Treatment Satisfaction
  • Knowledge Acquisition Disability Nos
  • Anxiety
  • Depression
  • Quality of Life
  • Relation, Family
  • Acceptance of Diagnosis
  • Stigma of Mental Illness
  • Participation

Interventions

BEHAVIORAL

Psychoeducation for Adults With Autism and Their Significant Others/Family members (Prisma)

Psychoeducation in groups

BEHAVIORAL

Treatment as usual/standard care

Standard care at disability/habilitation services.

Sponsors & Collaborators

  • Region Stockholm

    collaborator OTHER_GOV

  • Karolinska Institutet

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-09-01
Primary Completion
2020-09-15
Completion
2020-09-15

Countries

  • Sweden

Study Locations

Related Clinical Trials

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04460976 on ClinicalTrials.gov